Overexploitation of natural resources to meet human needs has considerably impacted CO2 emissions, contributing to global warming and severe climatic change. This review furnishes an understanding of the sources, brutality, and effects of CO2 emissions and compelling requirements for metamorphosis from a linear to a circular bioeconomy. A detailed emphasis on microalgae, its types, properties, and cultivation are explained with significance in attaining a zero-carbon circular bioeconomy. Microalgal treatment of a variety of wastewaters with the conversion of generated biomass into value-added products such as bio-energy and pharmaceuticals, along with agricultural products is elaborated. Challenges encountered in large-scale implementation of microalgal technologies for low-carbon circular bioeconomy are discussed along with solutions and future perceptions. Emphasis on the suitability of microalgae in wastewater treatment and its conversion into alternate low-carbon footprint bio-energies and value-added products enforcing a zero-carbon circular bioeconomy is the major focus of this review.
1,2-dimethylhydrazine (DMH) is a member in the class of hydrazines, strong DNA alkylating agent, naturally present in cycads. DMH is widely used as a carcinogen to induce colon cancer in animal models. Exploration of DMH-induced colon carcinogenesis in rodent models provides the knowledge to perceive the biochemical, molecular, and histological mechanisms of different stages of colon carcinogenesis. The procarcinogen DMH, after a series of metabolic reactions, finally reaches the colon, there produces the ultimate carcinogen and reactive oxygen species (ROS), which further alkylate the DNA and initiate the development of colon carcinogenesis. The preneolpastic lesions and histopathological observations of DMH-induced colon tumors may provide typical understanding about the disease in rodents and humans. In addition, this review discusses about the action of biotransformation and antioxidant enzymes involved in DMH intoxication. This understanding is essential to accurately identify and interpret alterations that occur in the colonic mucosa when evaluating natural or pharmacological compounds in DMH-induced animal colon carcinogenesis.